These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma. Zimmerman TJ; Kaufman HE Arch Ophthalmol; 1977 Apr; 95(4):601-4. PubMed ID: 322648 [TBL] [Abstract][Full Text] [Related]
29. [Systemic adverse affects of beta-blocking agents used in local treatment of the eye]. Laake K Tidsskr Nor Laegeforen; 1980 Mar; 100(7):453. PubMed ID: 7385201 [No Abstract] [Full Text] [Related]
32. Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Kanno M; Araie M; Masuda K; Takase M; Kitazawa Y; Shiose Y; Azuma I; Ogawa N; Ohdo S Arzneimittelforschung; 2006; 56(11):729-34. PubMed ID: 17220049 [TBL] [Abstract][Full Text] [Related]
33. Atrial fibrillation, pharmacological cardioversion and topical ophthalmic beta-blocker use. Patane' S; Marte F; Di Bella G; Pugliatti P Int J Cardiol; 2008 Jun; 126(3):e43-6. PubMed ID: 17418438 [No Abstract] [Full Text] [Related]
34. Betaxolol and timolol. A comparison of efficacy and side effects. Berry DP; Van Buskirk EM; Shields MB Arch Ophthalmol; 1984 Jan; 102(1):42-5. PubMed ID: 6367723 [TBL] [Abstract][Full Text] [Related]